← Signals · Healthcare · TSX
$EPRX
Eupraxia Pharmaceuticals
Signal as of July 25, 2026  ·  90-day rolling window  ·  Biotechnology & Life Sciences
Confluence Score
62
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 60–74 have historically hit 49% of the time (avg +5.2% over 90 days, 1310 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
62
Insider Activity (90d)
5
1 buyer  ·  $114K  ·  open-market only
Current Price
$8.98
CAD  ·  5-min cache
Market Cap
$584M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSX:EPRX
Insider Transactions
90-day window  ·  14 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jun 25, 2026 Pott, Amy Comp. Grant Buy 20,000
Jun 25, 2026 Pott, Amy Comp. Grant Buy 40,000 $8.89 +1.0%  · 37d $356K
Jun 25, 2026 Tambiah, Jeyanesh Comp. Grant Buy 160,000 $8.89 +1.0%  · 37d $1.4M
Jun 25, 2026 Tambiah, Jeyanesh Comp. Grant Buy 50,000
Jun 25, 2026 Bazemore, Robert Jr. Comp. Grant Buy 40,000 $8.89 +1.0%  · 37d $356K
Jun 25, 2026 Bazemore, Robert Jr. Comp. Grant Buy 20,000
Jun 18, 2026 Bazemore, Robert Jr. Other Sell
Jun 18, 2026 Pott, Amy Other Sell
Jun 15, 2026 Rothwell, Alexander John Comp. Grant Buy 46,500
Jun 15, 2026 Helliwell, James Allen Comp. Grant Buy 104,500
Jun 15, 2026 Rothwell, Alexander John Comp. Grant Buy 156,250 $8.45 +6.3%  · 47d $1.3M
Jun 15, 2026 Helliwell, James Allen Comp. Grant Buy 351,500 $8.45 +6.3%  · 47d $3.0M
May 05, 2026 Helliwell, James Allen Exercise Sell 150,000 $0.76 $114K
May 05, 2026 Helliwell, James Allen Exercise Buy 150,000 $0.76 +1085.9%  · 88d $114K
Score uses open-market buys only  ·  0 open-market  ·  11 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 30 30 1 unique buyer (maximum conviction)
Buy/sell ratio 20 62% buys (5B / 3S)
Dollar value 25 $114K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 Avg 3% credibility (limited data)
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 62 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Political Footprint
Donations · lobbying · contracts

4 insiders linked to EPRX are also individual political donors — $6K across 7 donations (2013–2023).

Conservative Party of Canada · $6K

Sources: Elections Canada (individual donations only — corporate political donations banned federally since 2007), the federal Registry of Lobbyists, and federal contract disclosures. Insiders matched to donors by name. Shown for transparency from disclosed public records — this is not a Confluence Score input, implies no causal link between donations, lobbying, or contracts, and is not a claim of wrongdoing.

Indigenous Consultation
no records on file

No Indigenous consultation records on file for EPRX.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jul 15, 2026
Shares short
52,131
Net change
-14,899 (-22.2%)
History
Jul 15: 52,131
Jun 30: 67,030
Jun 15: 48,664
May 31: 66,945
May 15: 86,253
Apr 30: 70,640
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Clinical Trials
ClinicalTrials.gov  ·  3 trials
Phase Status Trial Updated
P1/P2 Recruiting A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis ( Mar 2026
P2 Completed Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients Wit Jun 2024
P1 Completed Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoar Sep 2021
Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and terminations are material catalysts for clinical-stage companies — not investment advice.
Boardroom Connections
1 insider also active elsewhere
Insider Other boards Also an insider at
Montalbano, John 1 MFC (77)
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Government Grants & Funding
21 federal awards  ·  $4.8M total
Program / Agreement Department Amount Start
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $700K Sep 2021
Industrial Research Assistance Program – Youth Employment Progra Contribution National Research Council Canada $36K Apr 2021
Industrial Research Assistance Program – Innovation Assistance P Contribution National Research Council Canada $76K Dec 2020
Industrial Research Assistance Program – Innovation Assistance P Contribution National Research Council Canada $202K Jun 2020
Innovation Assistance Program Contribution National Research Council Canada $142K Apr 2020
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $999K Feb 2019
Industrial Research Assistance Program – Contributions to Firms Contribution National Research Council Canada $924K Feb 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K Jan 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $5 Jan 2019
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K Sep 2018
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K May 2018
Research Training and Talent Development Grant Natural Sciences and Engineering Research Council of Canada $4K May 2018
Federal grants & contributions disclosed by the Government of Canada (Proactive Disclosure), matched to this issuer by legal name. Government funding can be a pre-revenue validation and capital signal. Display-only context, not a Confluence Score input.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.